Renal vascular responses to CORM-A1 in the mouse

Pharmacological Research

Volumn 54, Issue 1, 2006, Pages 24-29

  Ryan, Michael J ^a   Jernigan, Nikki L ^a   Drummond, Heather A ^a   McLemore Jr , Gerald R ^a   Rimoldi, John M ^b   Poreddy, Sambasiva R ^b   Gadepalli, Rama S V ^b   Stec, David E ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MISSISSIPPI   (United States)

Author keywords

Carbon monoxide; CORM A1; Interlobar arteries; Mouse; Renal blood flow

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; CALCIUM ACTIVATED POTASSIUM CHANNEL; CARBON MONOXIDE; CARBOXYHEMOGLOBIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; KIDNEY; KIDNEY BLOOD FLOW; KIDNEY BLOOD VESSEL; MALE; MOLECULAR PROBE; MOUSE; NONHUMAN; PRIORITY JOURNAL; VASODILATATION;

ANIMALS; BORANES; CARBON MONOXIDE; CARBONATES; CARBOXYHEMOGLOBIN; FEMALE; GUANYLATE CYCLASE; KIDNEY; MALE; MICE; MICE, INBRED C57BL; OXADIAZOLES; POTASSIUM CHANNELS, CALCIUM-ACTIVATED; QUINOXALINES; RENAL ARTERY; RENAL CIRCULATION; VASCULAR RESISTANCE; VASODILATION;

EID: 33744926180     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2006.01.012     Document Type: Article

References (32)

1. Abraham N.G., and Kappas A. Heme oxygenase and the cardiovascular-renal system. Free Radic Biol Med 39 (2005) 1-25
2. Kozma F., Johnson R.A., Zhang F., Yu C., Tong X., and Nasjletti A. Contribution of endogenous carbon monoxide to regulation of diameter in resistance vessels. Am J Physiol 276 (1999) R1087-R1094
3. Zhang F., Kaide J., Wei Y., Jiang H., Yu C., Balazy M., et al. Carbon monoxide produced by isolated arterioles attenuates pressure-induced vasoconstriction. Am J Physiol Heart Circ Physiol 281 (2001) H350-H358
4. Stocker R., Yamamoto Y., McDonagh A.F., Glazer A.N., and Ames B.N. Bilirubin is an antioxidant of possible physiological importance. Science 235 (1987) 1043-1046
5. Appleton S.D., Chretien M.L., McLaughlin B.E., Vreman H.J., Stevenson D.K., Brien J.F., et al. Selective inhibition of heme oxygenase, without inhibition of nitric oxide synthase or soluble guanylyl cyclase, by metalloporphyrins at low concentrations. Drug Metab Dispos 27 (1999) 1214-1219
6. Villamor E., Perez-Vizcaino F., Cogolludo A.L., Conde-Oviedo J., Zaragoza-Arnaez F., Lopez-Lopez J.G., et al. Relaxant effects of carbon monoxide compared with nitric oxide in pulmonary and systemic vessels of newborn piglets. Pediatr Res 48 (2000) 546-553
7. Nachar R.A., Pastene C.M., Herrera E.A., Riquelme R.A., Sanhueza E.M., Troncoso S., et al. Low-dose inhaled carbon monoxide reduces pulmonary vascular resistance during acute hypoxemia in adult sheep. High Alt Med Biol 2 (2001) 377-385
8. Clark J.E., Naughton P., Shurey S., Green C.J., Johnson T.R., Mann B.E., et al. Cardioprotective actions by a water-soluble carbon monoxide-releasing molecule. Circ Res 93 (2003) e2-e8
9. Motterlini R., Sawle P., Hammad J., Bains S., Alberto R., Foresti R., et al. CORM-A1: a new pharmacologically active carbon monoxide-releasing molecule. FASEB J 19 (2005) 284-286
10. Vera T., Henegar J.R., Drummond H.A., Rimoldi J.M., and Stec D.E. Protective effect of carbon monoxide-releasing compounds in ischemia-induced acute renal failure. J Am Soc Nephrol 16 (2005) 950-958
11. Guo Y., Stein A.B., Wu W.J., Tan W., Zhu X., Li Q.H., et al. Administration of a CO-releasing molecule at the time of reperfusion reduces infarct size in vivo. Am J Physiol Heart Circ Physiol 286 (2004) H1649-H1653
12. Motterlini R., Clark J.E., Foresti R., Sarathchandra P., Mann B.E., and Green C.J. Carbon monoxide-releasing molecules: characterization of biochemical and vascular activities. Circ Res 90 (2002) E17-E24
13. Alberto R., Ortner K., Wheatley N., Schibli R., and Schubiger A.P. Synthesis and properties of boranocarbonate: a convenient in situ CO source for the aqueous preparation of [(99m)Tc(OH(2))3(CO)3]+. J Am Chem Soc 123 (2001) 3135-3136
14. Ryan M.J., Didion S.P., Mathur S., Faraci F.M., and Sigmund C.D. PPAR(gamma) agonist rosiglitazone improves vascular function and lowers blood pressure in hypertensive transgenic mice. Hypertension 43 (2004) 661-666
15. Jernigan N.L., and Drummond H.A. Vascular ENaC proteins are required for renal myogenic constriction. Am J Physiol Renal Physiol 289 (2005) F891-F901
16. Rodkey F.L., Hill T.A., Pitts L.L., and Robertson R.F. Spectrophotometric measurement of carboxyhemoglobin and methemoglobin in blood. Clin Chem 25 (1979) 1388-1393
17. Wang R., Wang Z., and Wu L. Carbon monoxide-induced vasorelaxation and the underlying mechanisms. Br J Pharmacol 121 (1997) 927-934
18. Kaide J.I., Zhang F., Wei Y., Jiang H., Yu C., Wang W.H., et al. Carbon monoxide of vascular origin attenuates the sensitivity of renal arterial vessels to vasoconstrictors. J Clin Invest 107 (2001) 1163-1171
19. Arregui B., Lopez B., Garcia S.M., Valero F., Navarro C., and Fenoy F.J. Acute renal hemodynamic effects of dimanganese decacarbonyl and cobalt protoporphyrin. Kidney Int 65 (2004) 564-574
20. Rodriguez F., Zhang F., Dinocca S., and Nasjletti A. Nitric oxide synthesis influences the renal vascular response to heme oxygenase inhibition. Am J Physiol Renal Physiol 284 (2003) F1255-F1262
21. Sawle P., Foresti R., Mann B.E., Johnson T.R., Green C.J., and Motterlini R. Carbon monoxide-releasing molecules (CO-RMs) attenuate the inflammatory response elicited by lipopolysaccharide in RAW264.7 murine macrophages. Br J Pharmacol 145 (2005) 800-810
22. Wang R., and Wu L. The chemical modification of KCa channels by carbon monoxide in vascular smooth muscle cells. J Biol Chem 272 (1997) 8222-8226
23. Sandouka A., Fuller B.J., Mann B.E., Green C.J., Foresti R., and Motterlini R. Treatment with CO-RMs during cold storage improves renal function at reperfusion. Kidney Int 69 (2006) 239-247
24. Nara M., Dhulipala P.D., Ji G.J., Kamasani U.R., Wang Y.X., Matalon S., et al. Guanylyl cyclase stimulatory coupling to K(Ca) channels. Am J Physiol Cell Physiol 279 (2000) C1938-C1945
25. Li P.L., Jin M.W., and Campbell W.B. Effect of selective inhibition of soluble guanylyl cyclase on the K(Ca) channel activity in coronary artery smooth muscle. Hypertension 31 (1998) 303-308
26. + channels. Circ Res 97 (2005) 805-812
27. + channel. J Pharmacol Exp Ther 285 (1998) 659-664
28. Vargas F., Sabio J.M., and Luna J.D. Contribution of endothelium derived relaxing factors to acetylcholine induced vasodilatation in the rat kidney. Cardiovasc Res 28 (1994) 1373-1377
29. Teran F.J., Johnson R.A., Stevenson B.K., Peyton K.J., Jackson K.E., Appleton S.D., et al. Heme oxygenase-derived carbon monoxide promotes arteriolar endothelial dysfunction and contributes to salt-induced hypertension in Dahl salt-sensitive rats. Am J Physiol Regul Integr Comp Physiol 288 (2005) R615-R622
30. Imai T., Morita T., Shindo T., Nagai R., Yazaki Y., Kurihara H., et al. Vascular smooth muscle cell-directed overexpression of heme oxygenase-1 elevates blood pressure through attenuation of nitric oxide-induced vasodilation in mice. Circ Res 89 (2001) 55-62
31. Thorup C., Jones C.L., Gross S.S., Moore L.C., and Goligorsky M.S. Carbon monoxide induces vasodilation and nitric oxide release but suppresses endothelial NOS. Am J Physiol 277 (1999) F882-F889
32. Johnson F.K., and Johnson R.A. Carbon monoxide promotes endothelium-dependent constriction of isolated gracilis muscle arterioles. Am J Physiol Regul Integr Comp Physiol 285 (2003) R536-R541